Halozyme Therapeutics reported $75.67M in Operating Profit for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
DBV Technologies DBVT:US -16771000 3.29M
Acadia Pharmaceuticals ACAD:US $ -113.02M 68.36M
Agios Pharmaceuticals AGIO:US $ -98.44M 3.74M
Alnylam Pharmaceuticals ALNY:US $ -146.73M 47.83M
Amarin AMRN:US $ -28.31M 44.44M
Amgen AMGN:US $ 2500M 196M
Aptinyx Inc APTX:US $ -19379000 207K
Baxter International BAX:US $ 163M 183M
Cara Therapeutics CARA:US $ -27911000 5.61M
Cytokinetics CYTK:US $ -80.55M 58.85M
Eli Lilly And LLY:US $ 2404.3M 487.1M
Esperion Therapeutics ESPR:US $ -42989000 12.64M
Halozyme Therapeutics HALO:US $ 75.67M 19.14M
Immunogen IMGN:US $ -22.85M 11.7M
Intercept Pharmaceuticals ICPT:US $ -10.27M 10.59M
Intra Cellular Therapies ITCI:US $ -72.66M 13.34M
Intrexon XON:US $ -17.9M 2.59M
JAZZ PHA JAZZ:US $ 87.55M 38.17M
Mannkind MNKD:US $ -21.26M 2.71M
Minerva Neurosciences NERV:US $ -7.99M 13.39M
Nektar Therapeutics NKTR:US $ -116.56M 3.65M
Peregrine Pharmaceuticals PPHM:US $ 3.27M 0.88M
Pfizer PFE:US $ 9873M 5297M
Rigel Pharmaceuticals RIGL:US $ -26.26M 4.84M
United Therapeutics UTHR:US $ 286.3M 116.5M
Vanda Pharmaceuticals VNDA:US $ -7.67M 16.3M